Limit on cancer drug costs cleared by Oklahoma panel

Oklahoma City Republican Sen. Greg Treat introduced the bill, which was approved without opposition Wednesday and now heads to the full Senate.

The bill would say that health benefit plans couldn't place any additional costs or requirements for covering orally administered cancer medications that they don't also require for any other injected or intravenous drugs. The bill says a health plan is following the bill's rules if the costs per prescription are kept at less than $100.